Digistain We Save Patients From Avoidable Chemotherapy 50% of women with breast cancer suffer through expensive and potentially lethal chemotherapy they don't need. Digistain solves this problem by scanning biopsies in the infrared to measure the increase in cancerous DNA. We remove the guesswork from diagnosis The post We Save Patients From Avoidable Chemotherapy appeared first on DigiStain.
Digistain is an England-based healthcare technology platform that offers solutions such as cancer risk profiling and diagnostics for patients and physicians.